Hidradenitis suppurativahttps://en.wikipedia.org/wiki/Hidradenitis_suppurativa
Hidradenitis suppurativa jẹ ipo aiṣan-ẹjẹ onibaje ti o ni ijuwe nipasẹ iṣẹlẹ ti igbona ati wiwu. Iwọnyi jẹ irora ni igbagbogbo ati ṣiṣi silẹ, itusilẹ ito tabi pus. Awọn agbegbe ti o kan julọ ni awọn apa abẹ, labẹ awọn ọmu, ati ikun. Asọ aleebu wa lẹhin iwosan.

Idi deede jẹ igbagbogbo koyewa, ṣugbọn gbagbọ pe o kan apapọ ti jiini ati awọn ifosiwewe ayika. Nipa idamẹta awọn eniyan ti o ni arun na ni ọmọ ẹgbẹ ẹbi ti o kan. Awọn okunfa ewu miiran pẹlu isanraju ati mimu siga. Ipo naa kii ṣe nipasẹ ikolu, imototo ti ko dara.

Ko si iwosan ti a mọ. Gige ṣii awọn ọgbẹ lati gba wọn laaye lati ṣagbe ko ni abajade anfani pataki. Lakoko ti a ti lo awọn oogun apakokoro ni igbagbogbo, ẹri fun lilo wọn ko dara. Oogun ajẹsara le tun ṣe idanwo. Ninu awọn ti o ni arun ti o lewu sii, itọju ailera laser tabi iṣẹ abẹ lati yọ awọ ara ti o kan kuro le jẹ ṣiṣeeṣe. Ṣọwọn, ọgbẹ awọ kan le dagbasoke sinu akàn ara.

Ti awọn ọran kekere ti hidradenitis suppurativa wa pẹlu, lẹhinna iṣiro ti igbohunsafẹfẹ rẹ jẹ lati 1-4% ti olugbe. Awọn obinrin ni igba mẹta diẹ sii lati ṣe ayẹwo pẹlu rẹ ju awọn ọkunrin lọ. Ibẹrẹ jẹ igbagbogbo ni ọdọ agbalagba.

☆ Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
  • Hidradenitis suppurativa (ipele I) ni armpit. Eyi jẹ ọran kekere pupọ ti Hidradenitis suppurativa.
  • Hidradenitis suppurativa Ipele III
  • Hidradenitis suppurativa Ipele III ― Egbo inira.
  • Hidradenitis suppurativa Ipele III ― Awọn ọgbẹ ṣiṣi jẹ irora pupọ.
References What is hidradenitis suppurativa? 28209676 
NIH
Hidradenitis suppurativa jẹ ipo awọ ara ti o jẹ onibaje, ti n bọ pada, ati pe o le kan igbesi aye rẹ ni pataki. O ṣẹlẹ nipasẹ iredodo ninu awọn follicle irun, ati pe o nigbagbogbo nyorisi awọn akoran kokoro-arun. Awọn dokita maa n ṣe iwadii rẹ nipa wiwo iru awọn egbò ti o ni (bii awọn nodules, abscesses, tabi sinus tracts) , nibiti wọn wa (nigbagbogbo ninu awọn agbo awọ) , ati iye igba ti wọn pada wa ati bi o ṣe pẹ to ti wọn duro ni ayika.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
 Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What’s New? 34990004 
NIH
Awọn itọju ti kii ṣe ti isedale ati ti kii ṣe ilana ni a maa n lo nikan fun aisan kekere ati pe o le ni idapo pelu itọju isedale ati iṣẹ abẹ fun iwọntunwọnsi si arun ti o lagbara. Awọn ijinlẹ aipẹ pese ẹri afikun ti imunadoko fun lilo awọn corticosteroids itasi taara sinu awọn ọgbẹ fun awọn ifunpa HS ati awọn ọgbẹ agbegbe. Pẹlupẹlu, ẹri wa ni iyanju pe lilo tetracyclines nikan le jẹ imunadoko bi apapọ clindamycin pẹlu rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
 Hidradenitis Suppurativa: A Systematic Review and Meta-analysis of Therapeutic Interventions 30924446
Ọpọlọpọ awọn itọju ni a lo fun hidradenitis suppurativa, pẹlu awọn egboogi, retinoids, antiandrogens, awọn oogun ajẹsara, awọn oogun egboogi-iredodo, ati itọju redio fun awọn egbo tete. Awọn itọju ti o ga julọ ti a ṣe iṣeduro jẹ adalimumab ati itọju ailera laser. Iṣẹ-abẹ, boya ilọkuro ti o rọrun tabi ilọkuro agbegbe pipe pẹlu gbigbe awọ ara, jẹ aṣayan ti o fẹ julọ fun àìdá, awọn ọran ilọsiwaju ti ko dahun daradara si awọn itọju miiran.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.